Risperidone in the treatment of psychoses in the elderly: A case report series

European Psychiatry

Volumn 17, Issue 2, 2002, Pages 96-103

  Bullock, R ^a   Libretto, S ^b  

^a VICTORIA HOSPITAL   (United Kingdom)

^b Janssen Cilag Ltd   (United Kingdom)

Author keywords

Atypical antipsychotic; Elderly; Geriatric; Psychoses; Risperidone

Indexed keywords

ACETYLSALICYLIC ACID; BETAHISTINE; BUMETANIDE; CITALOPRAM; CLOMIPRAMINE; DIAZEPAM; FLUPHENAZINE; HALOPERIDOL; MIRTAZAPINE; NEUROLEPTIC AGENT; RISPERIDONE; TEMAZEPAM; THIORIDAZINE; TRIFLUOPERAZINE;

AGED; ARTICLE; CAREGIVER; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GERONTOPSYCHIATRY; HEALTH CARE COST; HUMAN; LONG TERM CARE; MALE; MEDICAL RECORD; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0036247105     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(02)00634-X     Document Type: Article

References (31)

1. Dementia with Lewy bodies
2. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro
3. Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
4. Neuroleptic sensitivity in patients with dementia
5. A long-term, multicentre, open-label study of risperidone in elderly patients with psychosis
6. Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety
7. Risperidone: A new, novel (and better?) antipsychotic
8. Pharmacological profile of risperidone
9. Neuroleptic withdrawal in schizophrenic patients
10. Risperidone: A review of its pharmacology and therapeutic potential in the treatment of schizophrenia
11. Lewy body disease
12. Therapeutic dose: Serum level relationships of risperidone and active metabolite in a geriatric population
13. Risk of tardive dyskinesia in older patients: A prospective longitudinal study of 266 outpatients
14. Newer antipsychotics and antidepressants for elderly people
15. Risperidone in the treatment of agitated and aggressive patients with dementia
16. The safety of risperidone: A post-marketing study on 7684 patients
17. Risperidone in the treatment of elderly patients with psychotic disorders
18. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: A case series
19. Risperidone in the treatment of schizophrenia
20. Neuroleptic sensitivity in patients with senile dementia of Lewy body type
21. Risperidone in the treatment of chronic schizophrenic patients: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
22. 2 receptors in demented patients with severe neuroleptic sensitivity
23. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
24. Outcome of risperidone therapy in elderly patients with chronic psychosis
25. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
26. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
27. Drugs QT interval abnormalities and ventricular arrhythmias
28. Risperidone in the elderly: A pharmacoepidemiological study